Results 191 to 200 of about 45,512 (293)
RAS Inhibitor RMC-7977 Blocks Vascular Overgrowth of NRAS<sup>Q61R</sup> Mutant Endothelial Cells. [PDF]
Alharbi S +6 more
europepmc +1 more source
New Primary and Secondary Prevention Measures for Cutaneous Melanoma: A Systematic Review
ABSTRACT Background Cutaneous melanoma is the deadliest type of skin cancer, with increasing incidence and mortality rates. Therefore, primary and secondary prevention are of utmost importance. Claims The objective is to evaluate new recent evidence on primary and secondary prevention strategies for cutaneous melanoma.
Maria Palau–del–Valle +2 more
wiley +1 more source
Characterizing the Mutational Landscape of In-Transit Melanoma Metastases. [PDF]
Camacho LQ +12 more
europepmc +1 more source
ABSTRACT Background Aberrant p53 expression may have prognostic significance in colorectal cancer; however, its role in patients with colorectal liver metastases (CRLM) who receive neoadjuvant chemotherapy but do not achieve pathological complete response (pCR) remains unclear.
Phat Thi Hong Ho +6 more
wiley +1 more source
Synchronous multiple primary colorectal cancer with discordant RAS status between primary lesions: a case report in an elderly patient. [PDF]
Guan J +5 more
europepmc +1 more source
Studio del ruolo biologico di NRAS mutato nel mieloma multiplo
NRAS fa parte della famiglia di proteine RAS, delle piccole GTPasi che permettono la trasduzione del segnale all’interno della cellula. È proteina monomerica che può avere due conformazioni, una legata a GDP “inattiva” e una legata a GTP “attiva”.
CAPECCHI, VALENTINA
core
ABSTRACT Background Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders with a risk of progression to acute myeloid leukemia (AML). MDS‐transformed AML (MDS‐AML) has a poor prognosis. The concurrent presence of DEK::CAN fusion gene positivity and WT1 overexpression is extremely rare and likely denotes a highly ...
Wanxiu Mao +5 more
wiley +1 more source

